We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BIB market cap is 84.72M. The company's latest EPS is USD 3.4717 and P/E is 15.55.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End 31 May 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.42M | 1.13M | 1.37M | 1.19M | 1.26M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | 92.15M | 37.95M | -78.19M | 6.65M | 5.47M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End 31 May 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 186.03M | 302.01M | 148.57M | 100.22M | 90.61M |
| Total Liabilities | 2.05M | 14.62M | 54.88M | 3.63M | 2.34M |
| Total Equity | 183.98M | 287.39M | 93.69M | 96.59M | 88.27M |
| Market Cap | 84.72M |
| Price to Earnings Ratio | 15.55 |
| Price to Sales Ratio | 67.57 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0.96 |
| Dividend Yield | - |
| Shares Outstanding | 1.58M |
| Average Volume (1 week) | 13.87k |
| Average Volume (1 Month) | 10k |
| 52 Week Change | -4.77% |
| 52 Week High | 69.56 |
| 52 Week Low | 47.195 |
| Spread (Intraday) | 0.14 (0.26%) |
| Company Name | ProShares Ultra NASDAQ Biotechnology |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https:// |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
